New Cost-Effective Report on Prescription Drug Programs Makes Information Management Easier

Pharmaceutical Government Affairs, Managed Care, Field Sales, and Product Managers All Agree SRWA Reports Offer Valuable Information at a Cost Effective Price

DOWNINGTOWN, PA (PRWEB) February 28, 2004 -- S. R. Ware Associates, Inc. (SRWA) announces the publication of a new, comprehensive, and cost-effective report on State Prescription Assistance Programs (SPAP). Every company needs to know what is happening with their products at the state level -- that is why SRWA has been providing cost-effective reports for small and big pharma since 1995.

The SPAP concept represents a trend that has broad implications for the way all pharmaceuticals are marketed at the state level," says Steve Ware, President of SRWA. States use SPAP programs to cover people who may not qualify for Medicaid or Medicare, but still need financial assistance with prescription drugs. Many states have considered or will implement some type of program in 2003 and 2004."

SRWA Reports Are Unique
SRWA Reports on SPAP are published annually and have information on:
• Who you need to see to add your drug to the SPAP,
• What states use a preferred drug list,
• Why issues affect the usage of your drug in the SPAP population, and
• How you can use this information to your advantage.

SRWAs new report is important for both small and large pharmaceutical companies because it:
• Alerts field and office staff to upcoming therapeutic class reviews, which is vital to long-term planning,
• Allows for the efficient use of knowledge and enhances communication and goal setting,
• Is a cost effective and inexpensive first-class reference, unique to the industry,
• Contains alerts and analyses about exempt classes such as mental health drugs,
• Provides an online password protected version (free!) that enables field personnel to instantly access data while on the road, and
• Has a comprehensive bibliography and reference list.

Innovative Concepts are a Trademark of SRWA
This is an innovative concept," says Ware. Targeted reports such as our SPAP report can enhance the value of new and established products as well as the value of the team managing the process. Many pharma companies do not have the field or home office staff to cover every state. Thats where we provide the helping hand."

Additional SRWA Reports are due to be released in 2004 and will cover Medicaid managed care and other drug programs. Contact SRWA for more information and a sample of our report.

About The SRWA Report©: SPAP
The SRWA Report is available from S. R. Ware Associates, Inc. as a comprehensive report published annually. To find out more about SRWA concepts, cost, and delivery times, call 610-321-6191 or e-mail SRWA info@srwa.net

About S. R. Ware Associates, Inc.
S. R. Ware Associates, Inc. (SRWA) opened its doors in 1995 as a contract consultant group focused on pre- and post-launch pharmaceutical, biotechnology, or laboratory products requiring approval from Medicaid, Medicare, or other entities. The companys prime focus is on marketing and market research, but also conducts sales and management training. SRWA President and founder Steve Ware is a 25-year veteran of pharmaceutical sales, market research, knowledge management, and opinion leader development. SRWA draws upon a cadre of experienced associates with expertise in lobbying, sales management, advocacy, and a variety of therapeutic areas.

More information about SRWA is available by visiting http://www.srwa.net